Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 258-649-2 | CAS number: 53585-53-8
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Genetic toxicity: in vivo
Administrative data
- Endpoint:
- in vivo mammalian somatic cell study: cytogenicity / erythrocyte micronucleus
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- From December 13, 1989 to April 20, 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- - Test was performed on males only instead of males and females, without any justification, - 5 rats were used but one gave a slide with insufficient cell density, leading to conclude with only 4 animals, - Positive control was not concurrently tested.
Data source
Reference
- Reference Type:
- study report
- Title:
- Unnamed
- Year:
- 1 990
- Report date:
- 1990
Materials and methods
Test guideline
- Qualifier:
- equivalent or similar to guideline
- Guideline:
- OECD Guideline 474 (Mammalian Erythrocyte Micronucleus Test)
- Version / remarks:
- Study conducted prior to the adoption of the most
- Deviations:
- yes
- Remarks:
- Animals were treated for 4 months; only one dose was tested: no cytotoxicity was elicited at this only tested dose level; only male animals were used; 1000 PCE were scored for micronuclei instead of at least 2000. 5 rats were used but one gave a slide wi
- GLP compliance:
- yes
- Type of assay:
- micronucleus assay
Test material
- Reference substance name:
- Dibenzylbenzene, ar-methyl derivative
- EC Number:
- 258-649-2
- EC Name:
- Dibenzylbenzene, ar-methyl derivative
- Cas Number:
- 53585-53-8
- Molecular formula:
- C21H20
- IUPAC Name:
- dibenzylbenzene, ar-methyl derivative
- Test material form:
- liquid
Constituent 1
Test animals
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River, France
- Age at study initiation: approximately 7 weeks old
- Weight at study initiation: Mean initial bodyweight for males was 185 g
- Fasting period before study: not reported
- Housing: individually; space allocated: 345 square cm x 17 cm
- Diet: a complete commercial diet from U..A.R, ad libitum
- Water: tap-water through automatic waterers, ad libitum
- Acclimation period: at least 1 week before beginning treatment
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 ± 2
- Humidity (%): 60 ± 10
- Air changes (per hr): 12
- Photoperiod (hrs dark / hrs light): 12/12
IN-LIFE DATES: From: 2 August To: 13 December 1989
Administration / exposure
- Route of administration:
- oral: gavage
- Vehicle:
- 10% aqueous gum arabic solution
- Details on exposure:
- PREPARATION OF DOSING SOLUTIONS:
They were prepared just before administration as suspensions in 10% aqueous gum arabic solution. - Duration of treatment / exposure:
- At least 120 days
- Frequency of treatment:
- daily
- Post exposure period:
- no
Doses / concentrations
- Dose / conc.:
- 500 mg/kg bw/day
- No. of animals per sex per dose:
- 5
- Control animals:
- yes, concurrent vehicle
- Positive control(s):
- Positive control test was designed for the validation of the purification method, but not for the validation of the specific assay with test substance. Cyclophosphamide was administred intraperitoneally as a single dose at 15 mg/kg bw. Test with positive control was conducted separately from the main study with test substance, but at the same period, i.e. January 3, 1990.
- Justification for choice of positive control(s): no
- Route of administration: intraperitoneally
- Doses / concentrations: 15 mg/kg bw
Examinations
- Tissues and cell types examined:
- Smears of bone marrow of each femur were prepared. Erythrocytes were examined.
- Details of tissue and slide preparation:
- CRITERIA FOR DOSE SELECTION:
The in vivo genotoxic potential of Jarylec DBT was assessed in the male rat as part of a 4-month toxicity study
TREATMENT AND SAMPLING TIMES ( in addition to information in specific fields):
Necropsy was performed from Day 134 to 143 (final kill, all surviving animais).
DETAILS OF SLIDE PREPARATION:
Rat bone marrow slides were prepared after purification and enrichment of polychromatic erythrocyte fractions according to Romagna and Staniforth's method (1989).
At the scheduled sacrifice times (from days 134 to 143), five mice per treatment were anaesthetized by pentobarbital and exsanguinated.
Immediately following sacrifice, the femurs were removed and the bone marrow was flushed with newborn calf serum (NCS) supplemented with 25 mM EDTA. The bone marrow cell suspension was purified in a column filled with a mixture of microcrystalline cellulose and alpha-cellulose fibres (50/50).
Elution was performed using 25 ml HBSS (calcium- and magnesium-free). The eluate was filtered at the column exit and centrifuged for 10 min
at 1700 rpm. The supernatant was drawn off and the remaining cell pellet was resuspended in 500 µl NCS. A step-gradient separation was performed using Percoll solutions (at 80% and 30%). After centrifugation for 10 min at 1700 rpm, the sharp band
at the interface of the 30/80% gradient was collected and diluted with HBSS. After an additional centrifugation at 1500 rpm for 5 minutes, the supernatant was discarded and cells were resuspended in 500 µl NCS. Purified cell suspension were diluted in NCS (1:28 or 1:40) and 50 µl were spread onto clean glass slides. The slides were stained with Wright using an automatic Hemostain equipment (Geometric Data Corporation). - PCE/NCE ratio was determined until a total of at least 1000 cells (PCE+NCE) were counted - A total of 1000 PCE was examined for micronuclei.
METHOD OF ANALYSIS:
Reading was performed using a microscope (immersion lens x 100). Evaluation of bone marrow differential cell counts involved:
- the number of micronucleated polychromatic cells per 1000 polychromatic erythrocytes,
- the number of micronucleated normochromatic cells during the readings;
- the ratio of polychromatic (PCE) to normochromatic (NCE) erythrocytes. Both cellular types were counted until the first 1000 PCE were numbered.
- the increase in micronucleated polychromatic cells indicates a possible genotoxic effect whereas the decrease in PCE/NCE ratio shows medullary toxicity. - Evaluation criteria:
- Criteria for recognizing the micronuclei are given below:
- shape and color giving them the aspect of small nuclei, with well defined outlines, 1/20th to 1/50th the size of an erythrocyte;
- structure identical to that of a nucleus (no refraction at focus);
- difference from an artefact which is an element appearing indifferently in all types of cells, and sometimes outside cells. - Statistics:
- The mean and standard error of the mean were calculated, and treated groups were compared with the control group using the Kruskal-Wallis non parametric test.When the test was significant (non homogeneous means), this method was used for group comparisons; when not, means were considered as homogeneous.
Results and discussion
Test results
- Key result
- Sex:
- male
- Genotoxicity:
- negative
- Toxicity:
- no effects
- Vehicle controls validity:
- valid
- Negative controls validity:
- not applicable
- Positive controls validity:
- valid
- Additional information on results:
- RESULTS OF DEFINITIVE STUDY (see table 1 in the field Remarks on results)
- Induction of micronuclei (for Micronucleus assay): no increase in the number of micronucleated, normochromatic or polychromatic cells was noted in animals treated with Jarylec DBT at 500 mg/kg/d.
- Ratio of PCE/NCE (for Micronucleus assay): no significant decrease in the PCE/NCE ratio was noted, indicating the absence of medullary toxicity of Jarylec DBT.
Applicant's summary and conclusion
- Conclusions:
- Dibenzylbenzene, ar-methyl derivative did not induce any increase in the proportion of micronuclei per cell after a 4-month treatment in the rat at 500 mg/kg bw/day by gavage.
- Executive summary:
As part of the 4-month toxicity study (see section 7.5.1 Repeated dose toxicity oral) with Dibenzylbenzene, ar-methyl derivative (JARYLEC DBT) administered orally by gavage (0, 5, 50, and 500 mg/kg/day) to Sprague-Dawley rats, bone marrow slides were collected in male animals to evaluate the number of micronuclei per 1000 polychromatic erythrocytes. Finally, only slides of control and high dose treated groups were read.
Bone marrow slides were prepared from 5 male rats/group after purification and enrichment of polychromatic fractions on Percoll gradient. Scoring of the number of micronucleated polychromatic cells per 1000 polychromatic erythrocytes, the number of micronucleated normochromatic cells during the reading, and the ratio of polychromatic (PCE) to normochromatic (NCE) erythrocytes was performed on control and high dose treated groups.
No increase in the number of micronucleated, normochromatic or polychromatic cells, and no significant decrease in the PCE/NCE ratio were noted in rats treated at 500 mg/kg bw/d for approximately 4 months.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.